Beijing Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BEIJING, and what generic and branded alternatives to BEIJING drugs are available?
BEIJING has six approved drugs.
There is one tentative approval on BEIJING drugs.
Drugs and US Patents for Beijing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beijing | FLUVASTATIN SODIUM | fluvastatin sodium | TABLET, EXTENDED RELEASE;ORAL | 209397-001 | Apr 26, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Beijing Yiling | ANASTROZOLE | anastrozole | TABLET;ORAL | 206037-001 | Nov 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Beijing Yiling | LETROZOLE | letrozole | TABLET;ORAL | 205869-001 | Nov 14, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.